Stay updated on PT2385 Tablets in Advanced RCC Clinical Trial
Sign up to get notified when there's something new on the PT2385 Tablets in Advanced RCC Clinical Trial page.

Latest updates to the PT2385 Tablets in Advanced RCC Clinical Trial page
- ChecktodayChange DetectedThe expected modernization date for the ClinicalTrials.gov data ingest has been updated from June 2025 to July 2025.SummaryDifference0.6%
- Check7 days agoNo Change Detected
- Check15 days agoChange DetectedThe web page has been updated from version 2.16.1 to version 2.16.2.SummaryDifference0.0%
- Check22 days agoChange DetectedThe web page has been updated to indicate that the ClinicalTrials.gov data ingest will be modernized in June 2025, allowing API users to provide input before implementation. Additionally, the revision number has been updated from v2.15.2 to v2.16.1.SummaryDifference0.9%
- Check51 days agoChange DetectedThe web page has been updated from version 2.15.0 to version 2.15.2, indicating a revision in the content or functionality of the page.SummaryDifference0.0%
- Check65 days agoChange DetectedThe web page has undergone significant changes, including the removal of detailed study objectives and criteria for a clinical trial involving MK-3795 in patients with advanced clear cell renal cell carcinoma (ccRCC), while adding a new revision number and identifiers related to the study.SummaryDifference17%
- Check72 days agoChange DetectedThe web page has been updated from version 2.14.3 to version 2.14.4.SummaryDifference0.0%
Stay in the know with updates to PT2385 Tablets in Advanced RCC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the PT2385 Tablets in Advanced RCC Clinical Trial page.